Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07003698

Postoperative Analgesic Efficacy of Recto Intercostal Nerve Block

Postoperative Analgesic Efficacy of Rectointercostal Nerve Block in Patients Undergoing Laparoscopic Cholecystectomy

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Ankara Etlik City Hospital · Other Government
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Laparoscopic cholecystectomy is a frequently performed surgery and the gold standard for the treatment of symptomatic gallstone disease. Although laparoscopic cholecystectomy is considered minimally invasive, it can cause moderate to severe pain in the postoperative period. Poorly controlled early postoperative pain impairs recovery quality and increases the risk of postoperative pulmonary complications, serving as a risk factor for chronic pain development. Multimodal analgesia, including opioids, is used to manage pain following laparoscopic cholecystectomy. However, opioid treatment may lead to side effects such as postoperative nausea and vomiting (PONV), respiratory depression, and constipation. The primary aim of this study is to evaluate the effect of recto-intercostal nerve block as part of multimodal analgesia on intraoperative opioid consumption and postoperative pain scores in patients undergoing laparoscopic cholecystectomy.

Conditions

Interventions

TypeNameDescription
PROCEDUREThe group without the rectointercostal nerve blockPatients in this group will be administered dexketoprofen 50 mg and tramadol 100 mg intravenously in the intraoperative period. These patients will not receive the rectointercostal nerve block.
PROCEDUREThe rectointercostal plane blockThe rectointercostal plane block is performed under ultrasound guidance before the surgical procedure and anesthesia induction, with the patient in the supine position. Additionally, patients in this group will be administered dexketoprofen 50 mg and tramadol 100 mg intravenously in the intraoperative period.

Timeline

Start date
2025-06-22
Primary completion
2025-12-11
Completion
2025-12-21
First posted
2025-06-04
Last updated
2025-06-04

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07003698. Inclusion in this directory is not an endorsement.